Another study on ginsenoside Rg1 attenuating sleep deprivation damage showed that the up-regulation of BCL2 may help to attenuate the neuronal damage caused by insomnia and play a protective role.[52] SOCS3 is a negative regulatory factor involved in cytokine signaling and immune responses. The gene discussed is BCL2; the disease is insomnia.